https://orcid.org/0000-0001-8176-3955
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Oyahida Khatun, Mansi Sharma, Rohan Narayan & Shashank Tripathi. (2023) SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction. Cellular and Molecular Life Sciences 80:12.
Crossref
Crossref
M. Bello-Perez, J. Hurtado-Tamayo, A. Z. Mykytyn, M. M. Lamers, R. Requena-Platek, D. Schipper, D. Muñoz-Santos, J. Ripoll-Gómez, A. Esteban, P. J. Sánchez-Cordón, L. Enjuanes, B. L. Haagmans & I. Sola. (2023) SARS-CoV-2 ORF8 accessory protein is a virulence factor. mBio 14:5.
Crossref
Crossref
Xiang Li, Hongliang Yan, Gary Wong, Wanli Ouyang & Jie Cui. (2023) Identifying featured indels associated with SARS-CoV-2 fitness. Microbiology Spectrum 11:5.
Crossref
Crossref
D. Hare, K.M. Dembicka, C. Brennan, C. Campbell, U. Sutton-Fitzpatrick, P.J. Stapleton, C.F. De Gascun & C.P. Dunne. (2023) Whole-genome sequencing to investigate transmission of SARS-CoV-2 in the acute healthcare setting: a systematic review. Journal of Hospital Infection 140, pages 139-155.
Crossref
Crossref
Minghua Li, Kasirajan Ayyanathan, Mark Dittmar, Jesse Miller, Iulia Tapescu, Jae Seung Lee, Marisa E. McGrath, Yong Xue, Sanjay Vashee, David C. Schultz, Matthew B. Frieman & Sara Cherry. (2023) SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. mBio.
Crossref
Crossref
Siddharth Singh Tomar & Krishna Khairnar. (2023) Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenario. Frontiers in Public Health 11.
Crossref
Crossref
Mitra Ranjbar, Ali Rahimi, Zeinab Baghernejadan, Atousa Ghorbani & Hossein Khorramdelazad. (2022) Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table. International Immunopharmacology 113, pages 109325.
Crossref
Crossref
Stephen W. Attwood, Sarah C. Hill, David M. Aanensen, Thomas R. Connor & Oliver G. Pybus. (2022) Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic. Nature Reviews Genetics 23:9, pages 547-562.
Crossref
Crossref
Shenghui Weng, Hangyu Zhou, Chengyang Ji, Liang Li, Na Han, Rong Yang, Jingzhe Shang & Aiping Wu. (2022) Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution. Microbiology Spectrum 10:2.
Crossref
Crossref
B. Lina. (2022) Les différentes phases de l’évolution moléculaire et antigénique des virus SARS-CoV-2 au cours des 20 mois suivant son émergence. Bulletin de l'Académie Nationale de Médecine 206:1, pages 87-99.
Crossref
Crossref
Yu-Nong Gong, Kuo-Ming Lee & Shin-Ru Shih. 2022. SARS-CoV-2. SARS-CoV-2
3
18
.
Alexander L Greninger & Danielle M Zerr. (2021) NGSocomial Infections: High-Resolution Views of Hospital-Acquired Infections Through Genomic Epidemiology. Journal of the Pediatric Infectious Diseases Society 10:Supplement_4, pages S88-S95.
Crossref
Crossref
Xue Liu, Liping Guo, Tiefeng Xu, Xiaoyu Lu, Mingpeng Ma, Wenyu Sheng, Yinxia Wu, Hong Peng, Liu Cao, Fuxiang Zheng, Siyao Huang, Zixiao Yang, Jie Du, Mang Shi & Deyin Guo. (2021) A comprehensive evolutionary and epidemiological characterization of insertion and deletion mutations in SARS-CoV-2 genomes. Virus Evolution 7:2.
Crossref
Crossref
Paolo Giuseppe Bonacci, Dalida Angela Bivona, Dafne Bongiorno, Stefano Stracquadanio, Mariacristina Massimino, Carmelo Bonomo, Alessia Stracuzzi, Paolo Pennisi, Nicolò Musso & Stefania Stefani. (2021) Low Represented Mutation Clustering in SARS-CoV-2 B.1.1.7 Sublineage Group with Synonymous Mutations in the E Gene. Diagnostics 11:12, pages 2286.
Crossref
Crossref
Sofya K. Garushyants, Igor B. Rogozin & Eugene V. Koonin. (2021) Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring. Communications Biology 4:1.
Crossref
Crossref
Antonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, Grégory Quéromès, Nicolas Guibert, Emilie Frobert, Maude Bouscambert, Mary-Anne Trabaud, Florence Allantaz-Frager, Guy Oriol, Valérie Cheynet, Constance d’Aubarede, Amélie Massardier-Pilonchery, Marlyse Buisson, Julien Lupo, Bruno Pozzetto, Pascal Poignard, Bruno Lina, Jean-Baptiste Fassier, Florence Morfin, Sophie Trouillet-Assant, Jerôme Adnot, Dulce Alfaiate, Alain Bergeret, André Boibieux, Florent Bonnet, Florence Brunel-Dalmas, Eurydice Caire, Barbara Charbotel, Pierre Chiarello, Laurent Cotte, Constance d’Aubarede, François Durupt, Vanessa Escuret, Pascal Fascia, Juliette Fontaine, Lucie Gaillot-Durand, Myriam Gillet, Matthieu Godinot, François Gueyffier, Laurence Josset, Matthieu Lahousse, Hélène Lozano, Djamila Makhloufi, Marie-Paule Milon, Frédéric Moll, David Narbey, Julie-Anne Nazare, Fatima Oria, Marielle Perry, Virginie Pitiot, Mélanie Prudent, Muriel Rabilloud, Audrey Samperiz, Isabelle Schlienger, Chantal Simon & Martine Valette. (2021) Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Scientific Reports 11:1.
Crossref
Crossref
Nathalie Chazal. (2021) Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?. Frontiers in Microbiology 12.
Crossref
Crossref
Carlos Farkas, Andy Mella, Maxime Turgeon & Jody J. Haigh. (2021) A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3′ Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity. Frontiers in Microbiology 12.
Crossref
Crossref
Thi Loi Dao, Van Thuan Hoang, Philippe Colson, Jean Christophe Lagier, Matthieu Million, Didier Raoult, Anthony Levasseur & Philippe Gautret. (2021) SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. Journal of Clinical Medicine 10:12, pages 2635.
Crossref
Crossref
Theofilos Toulkeridis, Rachid Seqqat, Marbel Torres Arias, Rodolfo Salazar-Martinez, Esteban Ortiz-Prado, Scarlet Chunga, Karla Vizuete, Marco Heredia-R & Alexis Debut. (2021) Volcanic Ash as a Precursor for SARS-CoV-2 Infection Among Susceptible Populations in Ecuador: A Satellite Imaging and Excess Mortality-Based Analysis. Disaster Medicine and Public Health Preparedness, pages 1-13.
Crossref
Crossref
Tzipi Braun, Shiraz Halevi, Rotem Hadar, Gilate Efroni, Efrat Glick Saar, Natahan Keller, Amnon Amir, Sharon Amit & Yael Haberman. (2021) SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition. Scientific Reports 11:1.
Crossref
Crossref
Yanina Panzera, Natalia Ramos, Lucía Calleros, Ana Marandino, Gonzalo Tomás, Claudia Techera, Sofía Grecco, Sandra Frabasile, Eddie Fuques, Leticia Coppola, Natalia Goñi, Viviana Ramas, Cecilia Sorhouet, Victoria Bormida, Analía Burgueño, María Brasesco, Maria Rosa Garland, Sylvia Molinari, Maria Teresa Perez, Rosina Somma, Silvana Somma, Maria Noelia Morel, Cristina Mogdasy, Héctor Chiparelli, Juan Arbiza, Adriana Delfraro & Ruben Pérez. (2021) Transmission cluster of COVID-19 cases from Uruguay: emergence and spreading of a novel SARS-CoV-2 ORF6 deletion. Memórias do Instituto Oswaldo Cruz 116.
Crossref
Crossref
Alessandra C. Setaro & Marta M. Gaglia. (2021) All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. Current Research in Virological Science 2, pages 100015.
Crossref
Crossref